Item 7.01 Regulation FD Disclosure
On January 10, 2022, Moleculin Biotech, Inc. (the "Company" conducted an
investor webinar using the presentation set forth as Exhibit 99.1 herein. The
information contained in Item 7.01 of this Current Report on Form 8-K, including
Exhibit 99.1, is being furnished and shall not be "filed" for the purpose of the
Securities Exchange Act of 1934, as amended ("Exchange Act"), nor shall it be
incorporated by reference in any filing under the Exchange Act or the Securities
Act of 1933, as amended ("Securities Act"), unless specifically identified
therein as being incorporated by reference.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
99.1 Investor Presentation dated January 10, 2022
104 Cover page Interactive Data File (formatted as Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses